Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid‐induced liver damage

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Pediatric Transplantation

• Publication date

  2000-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1034/j.1399-3046.2000.00115.xPMID 10933322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disorders of the Mitochondria

  1998cited by this paper
• Severe complex I deficiency in a case of neonatal‐onset lactic acidosis and fatal liver failure

  1997cited by this paper
• Cyclosporine Neurotoxicity

  1996cited by this paper
• Clinical presentation of mitochondrial disorders in childhood

  1996cited by this paper
• Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency.

  1995cited by this paper
• Neurologic complications in liver transplantation

  1993influential reference
• Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity

  1992cited by this paper
• Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphologic investigations.

  1991cited by this paper
• Increased risk of central nervous system toxicity in patients treated with ciclosporin and imipenem/cilastatin.

  1991cited by this paper
• Liver involvement in Alpers disease.

  1991cited by this paper
• Valproate Toxicity: Risk-Screening Strategies

  1991cited by this paper
• Cyclosporine neurotoxicity.

  1991cited by this paper
• Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA.

  1990cited by this paper
• Central nervous system complications in children treated with ciclosporin after renal transplantation.

  1990cited by this paper
• Cyclosporine neurotoxicity late after liver transplantation.

  1989cited by this paper
• Valproic acid hepatic fatalities.

  1989cited by this paper
• Cyclosporin associated demyelination following allogeneic bone marrow transplantation

  1989cited by this paper
• Cyclosporine-associated encephalopathy in childhood transplant patients.

  1988cited by this paper
• Valproic acid and the liver.

  1988cited by this paper
• Cyclosporine neurotoxicity in liver transplant recipients: report of three cases.

  1988cited by this paper
• Cyclosporin-associated cerebral lesions in liver transplantation.

  1988cited by this paper
• NEUROLOGIC COMPLICATIONS OF LIVER TRANSPLANTATION

  1988cited by this paper
• Valproic acid hepatic fatalities

  1987cited by this paper
• Cerebral blindness and encephalopathy with cyclosporin A toxicity

  1987cited by this paper
• Neurological complications following liver transplantation.

  1987cited by this paper
• Prolactinomas.

  1985cited by this paper
• Valproate: an updated review

  1985cited by this paper
• Hepatotoxicity to sodium valproate: a review.

  1984cited by this paper
• Infantile diffuse cerebral degeneration with hepatic cirrhosis.

  1976cited by this paper

• The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC derived Cortical Organoid of Alpers' Disease

  2023cites this paper
• Indications and Contraindications for Pediatric Liver Transplant

  2021cites this paper
• Status epilepticus in mitochondrial diseases and the role of POLG1 variants in the valproic-acid induced hepatotoxicity

  2019cites this paper
• POLG-related disorders and their neurological manifestations

  2018cites this paper
• Developmental and Inherited Liver Disease

  2018cites this paper
• Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate‐induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy

  2018cites this paper
• The role of POLG mutations in human disease

  2018cites this paper
• Effects of antiepileptic drugs on mitochondrial functions, morphology, kinetics, biogenesis, and survival.

  2017cites this paper
• Toxicity of Antiepileptic Drugs to Mitochondria.

  2016cites this paper
• Disturbances in mitochondrial DNA maintenance in neuromuscular disorders and valproate-induced liver toxicity

  2015cites this paper
• Management of Medical Comorbidity Associated with Epilepsy

  2015cites this paper
• MasquEradErs oF nonalCoholiC Fatty livEr disEasE A CME Case-Based Newsletter

  2014cites this paper
• Acute liver failure after valproate exposure in patients with POLG1 mutations and the prognosis after liver transplantation

  2014cites this paper
• Syndromes associated with mitochondrial DNA depletion

  2014cites this paper
• Acute liver failure after valproate exposure: Liver transplantation may be indicated beyond childhood

  2014cites this paper
• Gastrointestinal and hepatic manifestations of mitochondrial disorders

  2013cites this paper
• Adverse drug reactions induced by valproic acid.

  2013cites this paper
• Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders

  2012cites this paper
• Nuclear-Mitochondrial Intergenomic Communication Disorders

  2012cites this paper
• Complete Deletion of a POLG1 Allele in a Patient with Alpers Syndrome.

  2012cites this paper
• Degenerative Disorders Primarily of Gray Matter

  2012cites this paper
• 4 – Genetic and metabolic liver disease

  2012cites this paper
• Mitochondrial respiratory chain hepatopathies: role of liver transplantation. A case series of five patients.

  2012influential citation
• Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States.

  2011influential citation
• Mitochondrial disorders of DNA polymerase γ dysfunction: from anatomic to molecular pathology diagnosis.

  2011cites this paper
• Mitochondrial DNA depletion syndromes--many genes, common mechanisms.

  2010cites this paper
• A neurological perspective on mitochondrial disease.

  2010cites this paper
• Drugs interfering with mitochondrial disorders

  2010cites this paper
• Drug management in emergent liver transplantation of mitochondrial disorder carriers: review of the literature

  2010cites this paper
• DGUOK-Related Mitochondrial DNA Depletion Syndrome, Hepatocerebral Form

  2009cites this paper
• Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase &ggr; (POLG1)

  2009cites this paper
• Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ (POLG1)

  2008cites this paper
• Alpers syndrome: progressive neuronal degeneration of children with liver disease

  2007cites this paper
• Indications for pediatric liver transplantation. Data from the Heidelberg pediatric liver transplantation program.

  2007cites this paper
• Alpers syndrome: progressive neuronal degeneration of children with liver disease.

  2006cites this paper
• Alpers syndrome: progressive neuronal degeneration of children with liver disease

  2006cites this paper
• POLG1 Mutations Associated With Progressive Encephalopathy in Childhood

  2006cites this paper
• Metabolic Disorders in Childhood

  2004cites this paper
• Central-peripheral sensory axonopathy in a juvenile case of Alpers-Huttenlocher disease

  2003cites this paper
• Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic Drugs

  2002cites this paper
• Mechanisms of Liver Injury Relevant to Pediatric Hepatology

  2002cites this paper
• Liver transplantation: To do or not to do?

  2000cites this paper